170 related articles for article (PubMed ID: 20622023)
21. Associations between emotional tobacco brand attachment and quitting plans among Norwegian smokers and snus users.
Lund I; Lund M
Psychol Addict Behav; 2019 Sep; 33(6):561-566. PubMed ID: 31512887
[TBL] [Abstract][Full Text] [Related]
22. Snus undermines quit attempts but not abstinence: a randomised clinical trial among US smokers.
Carpenter MJ; Wahlquist AE; Burris JL; Gray KM; Garrett-Mayer E; Cummings KM; Alberg AJ
Tob Control; 2017 Mar; 26(2):202-209. PubMed ID: 27071730
[TBL] [Abstract][Full Text] [Related]
23. Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy.
Biazzo LL; Froshaug DB; Harwell TS; Beck HN; Haugland C; Campbell SL; Helgerson SD
Nicotine Tob Res; 2010 Jun; 12(6):567-73. PubMed ID: 20378640
[TBL] [Abstract][Full Text] [Related]
24. Smoking cessation interventions: a primer for physicians: Comment on "Use of varenicline for 4 weeks before quitting smoking".
Simon JA
Arch Intern Med; 2011 Apr; 171(8):777-8. PubMed ID: 21518947
[No Abstract] [Full Text] [Related]
25. Perceived Health Risks of Snus and Medicinal Nicotine Products.
Hatsukami DK; Vogel RI; Severson HH; Jensen JA; O'Connor RJ
Nicotine Tob Res; 2016 May; 18(5):794-800. PubMed ID: 26386473
[TBL] [Abstract][Full Text] [Related]
26. Contrasting snus and NRT as methods to quit smoking. an observational study.
Scheffels J; Lund KE; McNeill A
Harm Reduct J; 2012 Feb; 9():10. PubMed ID: 22376006
[TBL] [Abstract][Full Text] [Related]
27. Varenicline in the management of smoking cessation: a single technology appraisal.
Hind D; Tappenden P; Peters J; Kenjegalieva K
Health Technol Assess; 2009 Sep; 13 Suppl 2():9-13. PubMed ID: 19804684
[TBL] [Abstract][Full Text] [Related]
28. Which drug to be used in smoking cessation?
Tønnesen P
Pol Arch Med Wewn; 2008 Jun; 118(6):373-6. PubMed ID: 18619194
[TBL] [Abstract][Full Text] [Related]
29. Oral tobacco products: preference and effects among smokers.
Hatsukami DK; Jensen J; Anderson A; Broadbent B; Allen S; Zhang Y; Severson H
Drug Alcohol Depend; 2011 Nov; 118(2-3):230-6. PubMed ID: 21515003
[TBL] [Abstract][Full Text] [Related]
30. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.
Eisenberg MJ; Filion KB; Yavin D; Bélisle P; Mottillo S; Joseph L; Gervais A; O'Loughlin J; Paradis G; Rinfret S; Pilote L
CMAJ; 2008 Jul; 179(2):135-44. PubMed ID: 18625984
[TBL] [Abstract][Full Text] [Related]
31. Mediators of the effect of nicotine pre-treatment on quitting smoking.
Hajek P; Lewis S; Munafo M; Lindson N; Coleman T; Aveyard P;
Addiction; 2018 Dec; 113(12):2280-2289. PubMed ID: 30066385
[TBL] [Abstract][Full Text] [Related]
32. Real-World Effectiveness of Pharmaceutical Smoking Cessation Aids: Time-Varying Effects.
Chaiton M; Diemert LM; Bondy SJ; Cohen JE; Fung MD; Zhang BR; Ferrence RG
Nicotine Tob Res; 2020 Apr; 22(4):506-511. PubMed ID: 30260455
[TBL] [Abstract][Full Text] [Related]
33. Patterns of dual use of snus and cigarettes in a mature snus market.
Lund KE; McNeill A
Nicotine Tob Res; 2013 Mar; 15(3):678-84. PubMed ID: 22990221
[TBL] [Abstract][Full Text] [Related]
34. Gender differences in snus versus nicotine gum for cigarette avoidance among a sample of US smokers.
Allen A; Vogel RI; Meier E; Anderson A; Jensen J; Severson HH; Hatsukami D
Drug Alcohol Depend; 2016 Nov; 168():8-12. PubMed ID: 27610935
[TBL] [Abstract][Full Text] [Related]
35. Dual use of cigarettes and Swedish snuff (snus) among young adults in Northern Finland.
Hamari AK; Toljamo TI; Kinnula VL; Nieminen PA
Eur J Public Health; 2013 Oct; 23(5):768-71. PubMed ID: 23002233
[TBL] [Abstract][Full Text] [Related]
36. Flexible and extended dosing of nicotine replacement therapy or varenicline in comparison to fixed dose nicotine replacement therapy for smoking cessation: rationale, methods and participant characteristics of the FLEX trial.
Tulloch H; Pipe A; Els C; Aitken D; Clyde M; Corran B; Reid RD
Contemp Clin Trials; 2014 Jul; 38(2):304-13. PubMed ID: 24861558
[TBL] [Abstract][Full Text] [Related]
37. Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers.
Howard P; Knight C; Boler A; Baker C
Pharmacoeconomics; 2008; 26(6):497-511. PubMed ID: 18489200
[TBL] [Abstract][Full Text] [Related]
38. Nicotine replacement therapy, professional therapy, snuff use and tobacco smoking: a study of smoking cessation strategies in southern Sweden.
Lindström M
Tob Control; 2007 Dec; 16(6):410-6. PubMed ID: 18048619
[TBL] [Abstract][Full Text] [Related]
39. Factors predicting willingness to quit snus and cigarette use among young males.
Danielsson M; Lammi A; Siitonen S; Ollgren J; Pylkkänen L; Vasankari T
Sci Rep; 2023 Sep; 13(1):15126. PubMed ID: 37704673
[TBL] [Abstract][Full Text] [Related]
40. Association between snus use over time and smoking cessation in Norwegian smokers.
Lund I; Christiansen SG
Addiction; 2020 Jan; 115(1):170-174. PubMed ID: 31502348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
